Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

INTRODUCTION: Tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, is clinically effective against rheumatoid arthritis (RA), and several reports have indicated how TCZ influences a number of mechanisms underlying RA pathogenesis. However, it is still unclear whether TCZ affects inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Jun, Hashizume, Misato, Kaneko, Yuko, Yoshimoto, Keiko, Nishina, Naoshi, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332922/
https://www.ncbi.nlm.nih.gov/pubmed/25604867
http://dx.doi.org/10.1186/s13075-015-0526-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332922/
https://www.ncbi.nlm.nih.gov/pubmed/25604867
http://dx.doi.org/10.1186/s13075-015-0526-4

Ejemplares similares